GRACEcast Naturopathic/CAM Audio
GRACEcast Naturopathic/CAM Audio
cancerGRACE - H. Jack West, MD
MET-Amplified Lung Cancer: A New Target for XALKORI?
7 minutes Posted Jul 3, 2014 at 7:00 pm.
0:00
7:18
Download MP3
Show notes
Lung cancer patients with high MET amplification appear to do well on Xalcori (crizotinib), a drug that is approved for ALK positive patients.